MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.350
+0.080 (2.45%)
At close: Mar 9, 2026, 4:00 PM EDT
3.380
+0.030 (0.90%)
After-hours: Mar 9, 2026, 4:00 PM EDT
MDxHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 107.88 | 90.05 | 70.19 | 37.05 | 22.24 | Upgrade
|
| Revenue Growth (YoY) | 19.80% | 28.29% | 89.43% | 66.62% | 20.47% | Upgrade
|
| Cost of Revenue | 38.24 | 34.91 | 26.26 | 17.84 | 11.68 | Upgrade
|
| Gross Profit | 69.63 | 55.14 | 43.93 | 19.22 | 10.56 | Upgrade
|
| Selling, General & Admin | 69.49 | 63.78 | 59.93 | 49.01 | 31.37 | Upgrade
|
| Research & Development | 10.35 | 10.55 | 6.38 | 5.45 | 5.59 | Upgrade
|
| Amortization of Goodwill & Intangibles | 5.19 | 4.91 | 4.49 | 3.17 | 1.61 | Upgrade
|
| Other Operating Expenses | -0.99 | 0.62 | 0.46 | 0.07 | -0.12 | Upgrade
|
| Operating Expenses | 84.04 | 79.86 | 71.26 | 57.71 | 38.45 | Upgrade
|
| Operating Income | -14.41 | -24.72 | -27.33 | -38.49 | -27.88 | Upgrade
|
| Interest Expense | -10.11 | -7.63 | -5.58 | -2.64 | -1.88 | Upgrade
|
| Interest & Investment Income | - | 1.08 | 1.09 | 0.13 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -10.85 | 0.62 | -2.12 | -0.19 | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | -35.38 | -30.66 | -33.95 | -41.19 | -29.85 | Upgrade
|
| Asset Writedown | - | - | - | -0.04 | - | Upgrade
|
| Other Unusual Items | - | -7.03 | -9.15 | -2.81 | 0.85 | Upgrade
|
| Pretax Income | -35.38 | -37.69 | -43.1 | -44.04 | -29 | Upgrade
|
| Income Tax Expense | -1.86 | 0.38 | 0 | - | - | Upgrade
|
| Net Income | -33.52 | -38.07 | -43.1 | -44.04 | -29 | Upgrade
|
| Net Income to Common | -33.52 | -38.07 | -43.1 | -44.04 | -29 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 33 | 26 | 16 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 33 | 26 | 16 | 12 | Upgrade
|
| Shares Change (YoY) | 52.25% | 26.82% | 63.31% | 30.12% | 46.56% | Upgrade
|
| EPS (Basic) | -0.67 | -1.16 | -1.66 | -2.78 | -2.38 | Upgrade
|
| EPS (Diluted) | -0.67 | -1.16 | -1.66 | -2.78 | -2.38 | Upgrade
|
| Free Cash Flow | -3.35 | -19.72 | -24.24 | -36.91 | -23.44 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.60 | -0.94 | -2.33 | -1.92 | Upgrade
|
| Gross Margin | 64.55% | 61.23% | 62.58% | 51.87% | 47.50% | Upgrade
|
| Operating Margin | -13.36% | -27.45% | -38.93% | -103.87% | -125.37% | Upgrade
|
| Profit Margin | -31.07% | -42.28% | -61.40% | -118.86% | -130.41% | Upgrade
|
| Free Cash Flow Margin | -3.10% | -21.90% | -34.54% | -99.60% | -105.42% | Upgrade
|
| EBITDA | -5.2 | -18.96 | -22.18 | -33.58 | -24.85 | Upgrade
|
| EBITDA Margin | -4.82% | -21.05% | -31.59% | -90.62% | -111.72% | Upgrade
|
| D&A For EBITDA | 9.21 | 5.77 | 5.15 | 4.91 | 3.04 | Upgrade
|
| EBIT | -14.41 | -24.72 | -27.33 | -38.49 | -27.88 | Upgrade
|
| EBIT Margin | -13.36% | -27.45% | -38.93% | -103.87% | -125.37% | Upgrade
|
| Revenue as Reported | - | - | - | - | 22.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.